Crossmark

Ginsenoside Rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma

Published Online: 2022-11-17

Authors

Hwang, Hyun Ji

Hong, Seong Hwi

Moon, Hong Sang

Yoon, Young Eun

Park, Sung Yul
License Information

Text and Data Mining valid from 2022-11-17

Version of Record valid from 2022-11-17
More Information

Article History

Received: 23 March 2022

Accepted: 8 September 2022

First Online: 17 November 2022

Competing interests

: The authors declare no competing interests.

Document is current